Verona Pharma plc Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Verona Pharma plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2025.
  • Verona Pharma plc Operating Income (Loss) for the quarter ending June 30, 2025 was $13.3M.
  • Verona Pharma plc Operating Income (Loss) for the twelve months ending June 30, 2025 was -$56M, a 57.2% increase year-over-year.
  • Verona Pharma plc annual Operating Income (Loss) for 2024 was -$155M, a 129% decline from 2023.
  • Verona Pharma plc annual Operating Income (Loss) for 2023 was -$67.6M, a 10.8% increase from 2022.
  • Verona Pharma plc annual Operating Income (Loss) for 2022 was -$75.8M, a 3.32% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$56M $13.3M +$81.7M Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 -$138M -$10.3M +$16.9M +62.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 -$155M -$18.3M +$755K +3.95% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$155M -$40.7M -$24.4M -149% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$131M -$68.4M -$58.5M -587% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$72.6M -$27.2M -$5M -22.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 -$67.6M -$19.1M -$4.05M -26.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$63.5M -$16.3M -$1.18M -7.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$62.3M -$9.97M +$10.5M +51.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$72.9M -$22.2M +$2.87M +11.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$75.8M -$15M +$13.4M +47.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$89.2M -$15.1M -$21.7M -331% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$67.5M -$20.5M +$8.04M +28.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$75.5M -$25.1M -$2.21M -9.67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$73.3M -$28.5M -$760K -2.74% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$72.6M $6.56M +$27.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$100M -$28.5M -$17.6M -160% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$82.6M -$22.9M -$8.37M -57.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$74.3M -$27.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$21.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$11M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$14.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.